World Health Organization site
Skip Navigation Links

Please fill this short user satisfaction survey


Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 27 February 2024
Main ID:  NCT05096988
Date of registration: 14/10/2021
Prospective Registration: Yes
Primary sponsor: Vitaflo International, Ltd
Public title: Evaluation of PKU Sphere Liquid
Scientific title: A Study to Evaluate the Acceptability, Tolerance and Adherence of Children and Adults Consuming PKU Sphere Liquid, a Food for Special Medical Purposes (FSMP), for the Dietary Management of Phenylketonuria (PKU)
Date of first enrolment: November 23, 2021
Target sample size: 19
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT05096988
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
United Kingdom
Contacts
Name:     Anita Macdonald
Address: 
Telephone:
Email:
Affiliation:  Birmingham Women's and Children's NHS Foundation Trust
Key inclusion & exclusion criteria

Inclusion Criteria:

- Diagnosis of PKU requiring a low protein diet and protein substitute.

- Aged three (3) years and over

- Already taking a minimum of one GMP based protein substitute per day or have
previously taken one

- Able to comply with the study protocol and take the study product, according to the
opinion of the PI.

- Willingly given, written, informed consent from patient or parent/guardian.

- Willingly given, written assent (if appropriate).

Exclusion Criteria:

- Inability to comply with the study protocol, in the opinion of the investigator.

- Any co-morbidity, which, in the opinion of the investigator, would preclude
participation in the study.

- Diagnosis of persistent hyperphenylalaninaemia, or mild PKU not requiring dietary
intervention with a low protein diet and protein supplement.

- Unwilling/unable to take a GMP based protein substitute.

- Women who are pregnant / breastfeeding at the start of the study or planning to become
pregnant during the study period.

N.B.: Women who become pregnant unexpectedly during this study will be immediately
withdrawn from the study.



Age minimum: 3 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Phenylketonurias
Intervention(s)
Dietary Supplement: PKU sphere liquid
Primary Outcome(s)
Product acceptability rated on a Likert scale by the participant after four week intake [Time Frame: 4 weeks]
Questionnaire of self-reported changes in gastrointestinal tolerance during four week intake [Time Frame: 4 weeks]
Questionnaire of self-reported adherence to the prescribed amount of study product [Time Frame: 4 weeks]
Secondary Outcome(s)
Secondary ID(s)
20/NW/0273
MCT-GMPL-2018-02-21
271801
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history Please fill this short user satisfaction survey